Rachel Anne Scott is a Stanford, California based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Rachel Anne Scott is A194329 for Ophthalmology in California. Rachel Anne Scott is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Rachel Anne Scott speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Female
Practice Address:
300 Pasteur Dr, Stanford, California, 94305-2200
Phone:
650-723-4000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1609405877
NPI Enumeration Date:
08 Apr, 2020
NPI Last Update On:
09 Jul, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Rachel Anne Scott are as mentioned below.
License Number
Specialization
State
Status
A194329
Ophthalmology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
300 Pasteur Dr, Stanford, California
Zip:
94305-2200
Phone Number:
650-723-4000
Fax Number:
--
Patients can reach Rachel Anne Scott at 300 Pasteur Dr, Stanford, California or can call to book an appointment on 650-723-4000. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.